Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

PAWAN K SINGH

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1588003131
CMS profile
5063537
Location
COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,594.31

91 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $2,446.91 89
Education $147.40 2

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

PAWAN K SINGH

NPI 1588003131 · CMS profile ID 5063537

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

COLUMBUS, OH

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588003131?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
PAWAN K SINGH, NPI 1588003131, CMS profile ID 5063537. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588003131?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). PAWAN K SINGH, NPI 1588003131, CMS profile ID 5063537. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588003131?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
PAWAN K SINGH, NPI 1588003131, CMS profile ID 5063537, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1588003131?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

91 matching records · $2,594.31 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 91 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–91 of 91.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Sumitomo Pharma America, Inc. $19.6308/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030759699 CMS
AbbVie Inc. $6.5907/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029491 CMS
Teva Pharmaceuticals USA, Inc. $25.6107/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904429 CMS
Teva Pharmaceuticals USA, Inc. $15.2907/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904413 CMS
AbbVie Inc. $11.3807/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029487 CMS
AbbVie Inc. $28.8307/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029483 CMS
Neurocrine Biosciences, Inc. $22.3507/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052191423 CMS
Novocure Inc. $26.5006/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021076133 CMS
ARGENX US, INC. $20.7606/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060400029 CMS
Teva Pharmaceuticals USA, Inc. $29.3006/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904393 CMS
PFIZER INC. $24.0706/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049227441 CMS
SK Life Science, Inc. $22.9205/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054734717 CMS
Sumitomo Pharma America, Inc. $13.7205/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030759987 CMS
Neurocrine Biosciences, Inc. $24.6305/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052191393 CMS
AbbVie Inc. $11.7804/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029479 CMS
ARGENX US, INC. $35.9504/24/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060400069 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $111.6004/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1014025099 CMS
Teva Pharmaceuticals USA, Inc. $111.4504/19/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904367 CMS
Octapharma USA, Inc. $31.3104/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042735847 CMS
PFIZER INC. $21.0004/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049171425 CMS
Lilly USA, LLC $23.8304/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031993209 CMS
AbbVie Inc. $16.5603/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029475 CMS
Sumitomo Pharma America, Inc. $7.0203/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030760053 CMS
SK Life Science, Inc. $119.2303/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1054735125 CMS
Teva Pharmaceuticals USA, Inc. $23.4203/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904329 CMS
PFIZER INC. $24.1803/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049613883 CMS
UCB, Inc. $22.9303/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021928429 CMS
Neurocrine Biosciences, Inc. $23.0903/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052191329 CMS
Sumitomo Pharma America, Inc. $9.9702/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030760029 CMS
PFIZER INC. $13.8102/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049523123 CMS
AbbVie Inc. $20.3802/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029471 CMS
PFIZER INC. $14.0702/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049575695 CMS
Sumitomo Pharma America, Inc. $19.3602/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030759919 CMS
Neurocrine Biosciences, Inc. $25.1302/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1052191325 CMS
AbbVie Inc. $28.0202/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029467 CMS
Sumitomo Pharma America, Inc. $19.8502/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030759907 CMS
AbbVie Inc. $123.6901/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999029463 CMS
Teva Pharmaceuticals USA, Inc. $40.9101/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1056904307 CMS
Octapharma USA, Inc. $23.8301/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1042735841 CMS
Sumitomo Pharma America, Inc. $12.8901/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1030760001 CMS
UCB, Inc. $36.4501/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021928437 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $859.58 9
PY2020 $405.40 5
PY2021 $287.86 11
PY2022 $2,035.33 58
PY2023 $2,594.31 91
PY2024 $406.69 5
PY2025 $832.25 8

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $59,657.88 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

13 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $650.00 12/01/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744992
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $429.00 12/01/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744998
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $21,985.78 09/05/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744994
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,300.00 08/20/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744976
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $487.88 08/01/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233745000
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $4,583.00 05/23/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744984
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $715.00 05/23/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744988
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,300.00 05/23/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744990
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $390.00 05/21/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744980
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $19,179.48 05/07/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744982
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $237.22 04/01/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744978
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $455.25 04/01/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744986
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $7,945.27 01/15/2025 Non-covered Recipient Entity
The Ohio State University
ONC201 for the Treatment of Newly Diagnosed H3 K27M-mutant Diffuse Glioma Following Completion of Radiotherapy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study No dispute reported 06/30/2026 1233744996